Amin Khattab, Fahad Dakilallah Aljohani, Roa Halawani, Heba Mahmoud Eltahir, Ahmed M. Shehata, Saleh K. Ihmaid, Ahmed Aldhafiri, Mekky Abouzied, Najwa M. Almaghrabi, Heba M. H. Matar, Hossein M. Elbadawy & Hanaa Wanas·Journal of Pharmaceutical Research International·2021
This is a single center, retrospective, observational study carried out in Ohud hospital, the main referral hospital for SARS-CoV-2 infections in the region of Madinah, Kingdom of Saudi Arabia. The study was carried on hospitalized patients with moderate to severe symptoms, inclu...
Open access
Research Article10.9734/jpri/2021/v33i47A32988
Hossein Mostafa Elbadawy, Amin Khaled Khattab, Fahad Dakilallah Aljohani, Mekky Abouzied, Mohannad A. Bahlaq, Khalid Abdelkarim Abdalla, Sultan Hamid M. Aljohani, Heba M. Eltahir, Rania K. Alharbi, Talal Aljumaidi, Muayad Albadrani, Mohannad A. Almikhlafi & Ahmed Aldhafiri·Journal of Pharmaceutical Research International·2023
Background: SARS-CoV-2 infections emerged in China and spread globally causing the Corona virus disease 2019 (COVID19) pandemic. Dispersed reports from different countries reported the possibility of the incidence of SARS-CoV-2 reinfection in individual reported cases. The aim of...
Open access
Research Article10.9734/jpri/2023/v35i167382
Abdulhadi M. Alqahtani, Saja H. Almazrou, Khaled Alqahtani, Pendo Ntinika, Mohammed Alshahrani, Basmah F. Alqahtani, Amin K. Khattab, Sheikhah A. Alyahya, Fahad Dakilallah Aljohani & Hossein M. Elbadawy·Journal of Pharmaceutical Research International·2021
Background: Proton pump inhibitor (PPI)–coated prodrugs remain inactive until they enter the alkaline atmosphere of the duodenum, where they are absorbed and transmitted to parietal cells. This study aimed to evaluate the impact of PPI medication on patients with coronavirus dis...
Open access
Research Article10.9734/jpri/2021/v33i60B34994